Dermata Therapeutics News

Dermata Therapeutics | EFFECT: Others

Dec 18, 2023 00:15 ET

Dermata Therapeutics | 424B3: Prospectus

Dec 15, 2023 17:00 ET

Dermata Therapeutics | EFFECT: Others

Jul 28, 2023 00:15 ET

Dermata Therapeutics | 424B4: Prospectus

Jul 27, 2023 16:50 ET

Dermata Therapeutics | 424B5: Prospectus

May 25, 2023 17:26 ET

Dermata Therapeutics | 424B3: Prospectus

Mar 20, 2023 17:41 ET

Dermata Therapeutics | 424B4: Prospectus

Mar 20, 2023 09:00 ET

Dermata Therapeutics | EFFECT: Others

Mar 17, 2023 00:15 ET

Dermata Therapeutics | EFFECT: Others

Nov 28, 2022 00:15 ET

Dermata Therapeutics | 424B3: Prospectus

Jun 24, 2022 17:11 ET

Dermata Therapeutics | 424B3: Prospectus

May 19, 2022 16:05 ET

Dermata Therapeutics | EFFECT: Others

May 16, 2022 00:15 ET

Dermata Therapeutics | 424B4: Prospectus

May 13, 2022 17:06 ET

Dermata Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 4, 2022 16:58 ET

Dermata Therapeutics | 424B3: Prospectus

Sep 1, 2021 16:56 ET

Dermata Therapeutics | 424B4: Prospectus

Aug 16, 2021 16:54 ET

Dermata Therapeutics | EFFECT: Others

Aug 13, 2021 00:15 ET

Dermata Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Aug 11, 2021 17:15 ET

Dermata Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 12, 2021 16:56 ET